Jardí M, Inglés-Esteve J, Burgal M, Azqueta C, Velasco F, López-Pedrera C, Miles L A, Félez J
Institut Recerca Oncologica, Hospital Duran i Reynals, Barcelona, Spain.
Thromb Haemost. 1996 Dec;76(6):1009-19.
The urinary type plasminogen activator, urokinase (uPA) is localized on the cell surface through the binding of a specific receptor, the uPA receptor (uPAR). The uPA localization enhances plasmin formation on the cell surface and facilitates cell migration. The cellular and tissue distribution of uPAR is not fully established. We have analyzed uPAR expression in nine leukemic cell lines of distinct lineages and maturational states and correlated this with expression of plasminogen receptors, tissue-type plasminogen activator (tPA) receptors and LDL receptor-related protein (LRP). The most immature and least differentiated cell line (an erythro-myeloid cell line) and cells of lymphoid lineage, did not express uPAR, whereas cells differentiated along the myelo-monocytic pathway displayed this receptor. Plasminogen and tPA receptors were expressed by all leukemic cell lines and by all nucleated peripheral blood cells but B and T lymphocytes were negative for cell surface expression of both uPAR and LRP while monocytes and neutrophils were positive for expression of both uPAR and LRP. PMA stimulation induced surface expression of uPAR in lymphocytes but did not induce expression of LRP by these cells. In contrast, lymphoid cell lines were negative for uPAR expression even after PMA stimulation, indicating differences in regulation of uPAR expression between lymphocytes and lymphoid cell lines. The pattern of uPAR expression on leukemic cell lines was also studied on bone marrow blast cells from leukemic patients. Only the most mature myeloid cells expressed uPAR on their surfaces. In contrast, M3 leukemic cells and other blast cells displaying lymphoid markers such as TdT (+) and/or CD2 (+) did not express intracellular or cell-surface associated uPAR, indicating an heterogeneity among these promyelocytic cells and suggesting that uPAR may be a useful marker for leukemia typing. Myeloid blast cells from some patients contained intracellular pools of uPAR but displayed no receptor on the cell surface, suggesting that translocation may be a mechanism regulating uPAR expression in these cells. The comparison of uPAR expression between these cell lines and peripheral blood cells and it correlation with plasminogen receptors, tPA receptors and LRP expression offers new insights regarding potential mechanisms for regulation of uPA-uPAR-mediated pericellular proteolysis.
尿型纤溶酶原激活剂,即尿激酶(uPA),通过与特定受体——uPA受体(uPAR)结合而定位在细胞表面。uPA的这种定位增强了细胞表面纤溶酶的形成,并促进细胞迁移。uPAR在细胞和组织中的分布尚未完全明确。我们分析了9种不同谱系和成熟状态的白血病细胞系中uPAR的表达情况,并将其与纤溶酶原受体、组织型纤溶酶原激活剂(tPA)受体和低密度脂蛋白受体相关蛋白(LRP)的表达进行了关联分析。最不成熟、分化程度最低的细胞系(一种红系-髓系细胞系)以及淋巴系细胞,不表达uPAR,而沿髓单核细胞途径分化的细胞则表达该受体。所有白血病细胞系以及所有有核外周血细胞均表达纤溶酶原和tPA受体,但B淋巴细胞和T淋巴细胞的uPAR和LRP细胞表面表达均为阴性,而单核细胞和中性粒细胞的uPAR和LRP表达均为阳性。佛波酯(PMA)刺激可诱导淋巴细胞表面表达uPAR,但不会诱导这些细胞表达LRP。相反,即使经过PMA刺激,淋巴系细胞系的uPAR表达仍为阴性,这表明淋巴细胞和淋巴系细胞系在uPAR表达调控方面存在差异。我们还研究了白血病患者骨髓原始细胞中白血病细胞系上uPAR的表达模式。只有最成熟的髓系细胞在其表面表达uPAR。相比之下,M3白血病细胞和其他显示淋巴标记如末端脱氧核苷酸转移酶(TdT)(+)和/或CD2(+)的原始细胞不表达细胞内或细胞表面相关的uPAR,这表明这些早幼粒细胞之间存在异质性,并提示uPAR可能是白血病分型的一个有用标记。一些患者的髓系原始细胞含有细胞内uPAR池,但细胞表面未显示受体,这表明转运可能是调节这些细胞中uPAR表达的一种机制。这些细胞系与外周血细胞之间uPAR表达的比较及其与纤溶酶原受体、tPA受体和LRP表达的相关性,为uPA-uPAR介导的细胞周围蛋白水解调控的潜在机制提供了新的见解。